Here's Why CRISPR Therapeutics AG (CRSP) Fell More Than Broader Market

What happened: CRISPR Therapeutics AG ($CRSP) closed at $51.36, down 5.34% from the prior day, a steeper loss than the S&P 500, Dow, and Nasdaq. Key numbers: Close $51.36, down 5.34%. S&P 500 fell 1.82%, Dow 1.09%, Nasdaq 2.86%. Prior session shares lost 2.13%. Projected quarterly EPS -$1.06, revenue $9.95 million. Why it matters: The stock lagged the broader market and the Medical sector, which gained 5.28%. Investors are watching the upcoming earnings disclosure and analyst estimate revisions, with the consensus EPS estimate up 0.59% over 30 days. Market: -5.2% today ($51.42), -4.4% YTD, 0.8x vol — as of 22:46 UTC

CRISPR Therapeutics AG ($CRSP) closed at $51.36, down 5.34% from the prior day, a steeper loss than the S&P 500, Dow, and Nasdaq.

The stock lagged the broader market and the Medical sector, which gained 5.28%. Investors are watching the upcoming earnings disclosure and analyst estimate revisions, with the consensus EPS estimate up 0.59% over 30 days. Market: -5.2% today ($51.42), -4.4% YTD, 0.8x vol — as of 22:46 UTC